US filing analysis · 8-K
Sorted by SEC acceptance time (filing date when unavailable). Page 3 · 30 shown · up to 30 per page
BG
The company said it amended its securitization program using the Thirty-First Amendment to the Receivables Transfer Agreement dated October 30, 2026, extending the program's original termination date by 364 days to December 13, 2027.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Bunge GlobalBG$90.9-0.93%
DLTR
The company said it will report results for Q3 of fiscal 2026, which ended on October 31, 2026, before the stock market opens on Tuesday, November 24, 2026.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Dollar TreeDLTR$138-1.60%
AMGN
The company said total revenues for Q3 2026 rose 8% from Q3 2025 to $10.4 billion. It said product sales grew 8%, driven by volume growth.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
AmgenAMGN$436-0.64%
ERIE
The company said President and Chief Executive Officer Timothy G. NeCastro retired on November 2, 2026. It said the retirement date was accelerated from December 31, 2026, which it had previously announced as his retirement date, citing personal reasons.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Erie IndemnityERIE$272.48+1.32%
SWKS
The company said its combination with Qorvo was completed after the end of Q4, so its September quarter results are on a Skyworks standalone basis. Net revenue for the 3-month period was $1,045.7 million, and annual net revenue was $3,959.6 million.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Skyworks SolutionsSWKS$73.98-5.95%
PH
The company said shareholders elected 9 directors at its October 28, 2026 annual meeting, for terms ending at the 2027 annual meeting. Votes for each nominee ranged from 96,104,323 for Jennifer A. Parmentier to 101,755,541 for Denise Russell Fleming.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Parker-HannifinPH$873.11-3.64%
TRMB
Trimble said its board appointed Matthew C. Brown as a director on November 2, 2026, effective November 2, 2026.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
TrimbleTRMB$50.65-2.58%
EXPD
The company said revenue for Q3 2026 rose 42% year over year to $4.1 billion, and operating income increased 55% to $445 million. Diluted earnings per share rose 62% to $2.65.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Expeditors InternationalEXPD$192.56-0.30%
CMS
The company said it issued and sold $1,000,000,000 aggregate principal amount of its 6.800% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057 on November 3, 2026.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
CMS EnergyCMS$70.12+0.85%
AME
The company said its sales for Q3 2026 were $2.22 billion, up 17% from Q3 2025. GAAP diluted earnings per share were $1.85, and adjusted diluted earnings per share were $2.21.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
AMETEKAME$222.9-3.57%
ZBRA
The company said net sales for Q3 2026 (ended October 3) were $1,614 million, up from $1,320 million a year earlier, a 22.3% increase, and net income was $164 million, or $3.43 per diluted share.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Zebra TechnologiesZBRA$301.57-3.50%
ECHO
EchoStar said it put to a vote at its October 30, 2026 annual meeting of shareholders the election of 8 directors, including George R. Brokaw, to serve until the 2027 annual meeting.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
EchoStarECHO$84.3-8.68%
PNW
The company said Pinnacle West's net income attributable to common shareholders for Q3 2026 was $434.2 million, or $3.49 per diluted share. It was $413.2 million, or $3.39 per diluted share, in the same period a year earlier.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Pinnacle West CapitalPNW$101.28-0.73%
RVTY
Revvity said revenue for Q3 ended October 4, 2026 was $729 million, compared with $699 million a year earlier. Pro forma revenue was $710 million, and pro forma revenue growth was 7%. GAAP earnings per share from continuing operations was $0.56, compared with $0.41 a year earlier.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
RevvityRVTY$145.22-4.20%
FISV
Fiserv said GAAP revenue for Q3 2026 decreased 1% to $5.20 billion from the prior year period, with Merchant Solutions down 3% and Financial Solutions flat. GAAP loss per share for Q3 was $(11.17).
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
FiservFISV$55.93-1.22%
WAT
Waters said its reported revenue for Q3 2026 was $1.767 billion, consisting of organic revenue of $871 million and $896 million from the acquired Biosciences and Diagnostic Solutions businesses. Organic revenue grew 9% (10% in constant currency).
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
WatersWAT$440.45-3.51%
XEL
Xcel Energy said it priced a 2027-maturity 2.625% convertible senior notes offering in a principal amount of $2,200,000,000. The size was increased from the previously announced $2,000,000,000, and the sale is expected to close on November 5, 2026.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Xcel EnergyXEL$79.3-0.20%
KDP
The company said net sales for Q3 2026 rose 70.6% to $7.3 billion. It said legacy KDP net sales, excluding the contribution from the JDE Peet's acquisition, rose 8.6%. The company cited volume/mix growth of 6.5% and net price realization of 2.1% as factors.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Keurig Dr PepperKDP$34.85+1.28%
ADM
The company reported net earnings of $821 million for Q3 2026, diluted EPS of $1.70, and adjusted EPS of $1.77. It said adjusted EPS rose $0.85 from $0.92 in the same quarter of the prior year.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Archer-Daniels-MidlandADM$66.95-0.27%
SYY
Sysco said its 13-week Q1 (ended September 26, 2026) sales rose 2.8% to $21.7 billion, while operating income fell 10.4% to $717 million. The company cited acquisition-related costs for Jetro Restaurant Depot as the reason for the decline in operating income. Adjusted operating income increased 3.2% to $927 million.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
SyscoSYY$78.17+1.32%
BR
The company said Recurring revenues for Q1 of fiscal 2027 ended September 30, 2026 were $1,083 million, up 11% from $977 million a year earlier, and total revenues rose 5% to $1,669 million.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Broadridge Financial SolutionsBR$181.41-0.29%
ETN
The company said third-quarter sales for Q3 2026 rose to $8.9 billion, up 28% from Q3 2025, with organic sales growth of 19%, acquisitions contributing 8% and foreign exchange contributing 1%. Diluted earnings per share were $2.77, and adjusted earnings per share were $3.68.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
EatonETN$311.33-5.82%
HSIC
The company said net sales for Q3 2026 rose to $3.5 billion, up a total of 4.0% from a year earlier, reflecting internal sales growth of 3.1%, acquisition-driven growth of 0.7%, and a foreign currency exchange impact of 0.2%.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Henry ScheinHSIC$83.5-1.53%
PFE
Pfizer said revenues for Q3 2026 were $16,583 million ($16,654 million in the prior-year period), and net income attributable to Pfizer Inc. common shareholders was $3,242 million, down 8%. Reported diluted EPS was $0.56, and Adjusted diluted EPS was $0.87.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
PfizerPFE$27.4-0.51%
IT
The company reported net income of $214 million and diluted EPS of $3.35 for Q3 2026, which ended September 30 (3 months), compared with $35 million and $0.47, respectively, for the same period a year earlier.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
GartnerIT$174.49+1.27%
NWS
News Corp said it is authorized to repurchase Class A and Class B common stock from time to time for up to $1 billion in aggregate, and that this 2025 Repurchase Program was approved as of July 15, 2025.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
News CorpNWS$27.89-0.71%
GPN
The company said its board approved amendments to the Twelfth Amended and Restated Bylaws on October 28, 2026, in connection with recent amendments to the Georgia Business Corporation Code, and that the amendments take effect immediately.
US filing analysisUS8-K · Current reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Global PaymentsGPN$91.83+9.95%
MAA
The company said its operating partnership, Mid-America Apartments, L.P., priced senior unsecured notes carrying a 5.350% coupon and maturing on December 15, 2031, with an aggregate amount of $350,000,000.
US filing analysisUS8-K · Current reportPublished Nov 2, 2026 (UTC)SEC filing date Nov 2, 2026
Mid-America Apartment CommunitiesMAA$112.91-0.43%
WMB
The company said it filed a prospectus supplement to its Form S-3 registration statement (File No. 333-299764) on November 2, 2026.
US filing analysisUS8-K · Current reportPublished Nov 2, 2026 (UTC)SEC filing date Nov 2, 2026
Williams CompaniesWMB$64.31-2.75%
HCA
The company said in a press release on November 2, 2026 that its wholly owned subsidiary, HCA Inc., proposes to offer senior unsecured notes, subject to market and other considerations.
US filing analysisUS8-K · Current reportPublished Nov 2, 2026 (UTC)SEC filing date Nov 2, 2026
HCA HealthcareHCA$475.57+3.31%
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.